Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
Fund Manager Portfolios
Gain insights from the world's largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Search
Sign in
Sign up
Becton Dickinson
BDX
Market cap
$53.5B
Overview
Fund Trends
Analyst Outlook
Journalist POV
186.77
USD
--1.59
0.84%
At close
Updated
Oct 15, 4:00 PM EDT
Pre-market
After hours
181.00
--5.77
3.09%
1D
5D
1M
3M
6M
YTD
1Y
5Y
10Y
1 day
-0.84%
5 days
-3.79%
1 month
0.55%
3 months
4.74%
6 months
-7.56%
Year to date
-17.54%
1 year
-22.76%
5 years
-18.54%
10 years
39.66%
Positive
Neutral
Negative
Sentiment
3-Months
Positive
Neutral
41.8%
Negative
Positive
Neutral
Negative
Negative
Reuters
3 hours ago
Becton Dickinson's CFO to depart
Becton Dickinson said on Wednesday that its Chief Financial Officer Chris DelOrefice will depart the company, effective December 5, to pursue a new professional opportunity.
Neutral
PRNewsWire
4 hours ago
BD Announces CFO Transition Plan
Provides Preliminary Revenue for Fourth Quarter and Full Year Fiscal 2025 FRANKLIN LAKES, N.J. , Oct. 15, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today a transition plan under which Chris DelOrefice, executive vice president and chief financial officer (CFO), will depart the company effective Dec. 5, 2025, to pursue a new professional opportunity.
Positive
24/7 Wall Street
10 hours ago
5 Dividend Aristocrats Are Perfect for Boomers Seeking Growth and Income
While reaching retirement age can be both a blessing and a curse, relying on the U.S.
Negative
Zacks Investment Research
2 days ago
BD Stock Down Despite Making Progress in the Treatment of PAD Lesions
BDX advances PAD care with first patient enrolled in the XTRACT Registry using its dual-action Rotarex system.
Negative
Zacks Investment Research
5 days ago
BD Stock Down Despite Tie-Up to Boost Single-Cell Sequencing Workflow
BDX teams with Opentrons to automate single-cell sequencing, advancing its multiomics and biosciences strategy.
Positive
Zacks Investment Research
5 days ago
Why Becton Dickinson (BDX) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Neutral
PRNewsWire
6 days ago
BD to Announce Financial Results for its Fourth Quarter and Full Year of Fiscal 2025
FRANKLIN LAKES, N.J. , Oct. 9, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio webcast at 8 a.m.
Neutral
PRNewsWire
6 days ago
BD Reaches Major Milestone for Rotarex™ Catheter System with First Patient Enrolled in XTRACT™ Registry to Advance Real-World Evidence in Peripheral Artery Disease
FRANKLIN LAKES, N.J. , Oct. 9, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the enrollment of the first patient in the XTRACT™ Registry, a prospective, multi-center, single-arm, post-market registry study designed to evaluate the real-world performance of the Rotarex™ Catheter System in the treatment of patients with peripheral artery disease (PAD) lesions.
Neutral
PRNewsWire
7 days ago
BD and Opentrons Collaborate to Accelerate Single-Cell Multiomics Discoveries with Robotic Automation
FRANKLIN LAKES, N.J. , Oct. 8, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Opentrons Labworks, Inc., recognized worldwide for accessible lab automation with more than 10,000 robotic systems deployed, today announced a multi-year collaboration.
Positive
Zacks Investment Research
8 days ago
Why Becton Dickinson (BDX) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Show more
See News Rankings
Sign up
Sign in
Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
Fund Manager Portfolios
Gain insights from the world's largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Theme
Close